These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1535992)

  • 1. The direct binding of an HIV fragment with granulocytes from healthy subjects and infected patients.
    Gabrilovich DI; Kozich AT; Moshnikov SA; Pokrovsky VV
    Scand J Immunol; 1992 Mar; 35(3):369-72. PubMed ID: 1535992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synthetic peptide from HIV increases functional activity of granulocytes in healthy subjects.
    Gabrilovich DI; Kozhich AT; Rosly IM; Suvorova ZK; Ivanov VS; Moshnikov SA; Tchikin LD; Melichov VI; Pokrovsky VV
    AIDS; 1991 Jul; 5(7):889-92. PubMed ID: 1892596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection.
    Lynch G; Low L; Li S; Sloane A; Adams S; Parish C; Kemp B; Cunningham AL
    J Leukoc Biol; 1994 Sep; 56(3):266-72. PubMed ID: 7521897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional, discontinuous HIV-1 gp120 C3/C4 domain-derived, branched, synthetic peptide that binds to CD4 and inhibits MIP-1alpha chemokine binding.
    Howie SE; Fernandes ML; Heslop I; Hewson TJ; Cotton GJ; Moore MJ; Innes D; Ramage R; Harrison DJ
    FASEB J; 1999 Mar; 13(3):503-11. PubMed ID: 10064617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD4 on human peripheral blood neutrophils.
    Biswas P; Mantelli B; Sica A; Malnati M; Panzeri C; Saccani A; Hasson H; Vecchi A; Saniabadi A; Lusso P; Lazzarin A; Beretta A
    Blood; 2003 Jun; 101(11):4452-6. PubMed ID: 12531788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
    Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
    J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
    Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J
    Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active immunity against the CD4 receptor by using an antibody antigenized with residues 41-55 of the first extracellular domain.
    Lanza P; Billetta R; Antonenko S; Zanetti M
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11683-7. PubMed ID: 8265609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphorylation induced by C4 peptide constructs from HIV Gp120.
    Liu M; Zeng J; Robey FA
    Peptides; 1999; 20(2):185-91. PubMed ID: 10422873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection.
    Shapira-Nahor O; Golding H; Vujcic LK; Resto-Ruiz S; Fields RL; Robey FA
    Cell Immunol; 1990 Jun; 128(1):101-17. PubMed ID: 1971526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural studies on synthetic peptides from the principal neutralizing domain of HIV-1 gp120 that bind to CD4 and enhance HIV-1 infection.
    Dettin M; De Rossi A; Autiero M; Guardiola J; Chieco-Bianchi L; Di Bello C
    Biochem Biophys Res Commun; 1993 Mar; 191(2):364-70. PubMed ID: 8460995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4.
    Weinberg J; Liao HX; Torres JV; Matthews TJ; Robinson J; Haynes BF
    AIDS Res Hum Retroviruses; 1997 May; 13(8):657-64. PubMed ID: 9168234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations using photo affinity labeled analogues confirm the binding between sCD4 and the PND of HIV-1, MN.
    Dettin M; Scarinci C; Seraglia R; Di Bello C
    Biochem Biophys Res Commun; 1997 Dec; 241(2):584-8. PubMed ID: 9425315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic cleavage of a CD4 immunoadhesin generates crystallizable, biologically active Fd-like fragments.
    Chamow SM; Peers DH; Byrn RA; Mulkerrin MG; Harris RJ; Wang WC; Bjorkman PJ; Capon DJ; Ashkenazi A
    Biochemistry; 1990 Oct; 29(42):9885-91. PubMed ID: 2125484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competition of HLA-DR and a beta 2 domain peptide for HIV envelope glycoprotein gp120 binding to CD4.
    Autiero M; Houlgatte R; Martin M; Auffray C; Guardiola J; Piatier-Tonneau D
    Int Immunol; 1995 Feb; 7(2):191-7. PubMed ID: 7734415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple effects of CD4 CDR3-related peptide derivatives showing anti-HIV-1 activity on HIV-1 gp120 functions.
    Ohki K; Kimura T; Jones IM; Morita F; Ikuta K
    Vaccine; 1994 Mar; 12(4):343-50. PubMed ID: 8178557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short synthetic peptides derived from viral proteins compete with HIV gp120 for the binding to CD4 receptors.
    Chersi A; Pugliese O; Federico A; Viora M
    Viral Immunol; 2000; 13(4):547-54. PubMed ID: 11192301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 peptide-protein conjugates, but not recombinant human CD4, bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients.
    Ghetie V; Slaughter C; Wheeler HT; Uhr JW; Vitetta ES
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5690-3. PubMed ID: 2062847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.